Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Awakn Life Sciences Corp
C.AWKN
Alternate Symbol(s):
AWKNF
Healthcare
Psychedelics
Awakn Life Sciences Corp. is a Canada-based clinical-stage biotechnology company. The Company is developing therapeutics for substance use and mental health disorders, with a near-term focus on Alcohol Use Disorder (AUD). The Company's therapeutics are focused on the brain circuits that drive addiction, multiple receptors rather than the traditional single drug receptor targets. The Company...
operates through three segments: development, delivery and corporate. The development segment, which focuses on researching and developing psychedelic drugs and therapies, ketamine-assisted psychotherapy and methylenedioxy-methamphetamine (MDMA)-assisted psychotherapy to treat substance and behavioral addictions. The delivery segment, which includes a chain of medical psychedelic clinics across Europe and through licensing partners. The Company operates in Ireland and Canada. The Company’s development pipeline includes AWKN-001, AWKN-002 and MDMA.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:AWKN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Dec 19, 2024 6:23am
Buzz on the Bullboards: Three engaging TSX stocks with a holiday flavour
The TSX has experienced a rocky week, marked by five consecutive sessions of declines, but several stocks offer compelling opportunities.
read article.
(1)
•••
Badger66
X
View Profile
View Bullboard History
Comment by
Badger66
on Dec 18, 2024 11:16am
RE:RE:RE:RE:RE:Waiting
I haven't quite been able to iron out how they come to that 20 cents a share number, myself, or for that matter, how the volume of shares traded in Graft Polymer per day exceeds the float of
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 18, 2024 8:33am
New Press Release - Awakn Life Sciences Announces Credit Facility
Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, is pleased to announce that it has...
read article.
(290)
•••
TheBridge
X
View Profile
View Bullboard History
Comment by
TheBridge
on Dec 17, 2024 11:22pm
RE:RE:RE:RE:Waiting
If I calculated and understood it correctly it turns out to be 20 cents Canadian for each share of AWKN.
(0)
•••
JoeyCC
X
View Profile
View Bullboard History
Comment by
JoeyCC
on Dec 17, 2024 1:00pm
RE:RE:RE:RE:Waiting
TSX*
(0)
•••
JoeyCC
X
View Profile
View Bullboard History
Comment by
JoeyCC
on Dec 17, 2024 1:00pm
RE:RE:RE:Waiting
So my understanding from reading the news articles is that 1 awkn share is 46.67 graft polymer? Is my understanding correct? I am trading on the tax so I wonder what the conversion will be like for a
...more
(290)
•••
TheBridge
X
View Profile
View Bullboard History
Comment by
TheBridge
on Dec 17, 2024 10:40am
RE:RE:Waiting
Well it's not the New Year yet but we have a new name prior to the new year arriving. So we're Graft Polymer now, a UK entity and they obviously feel that we were worth taking out. Let's
...more
(290)
•••
TheBridge
X
View Profile
View Bullboard History
Comment by
TheBridge
on Dec 16, 2024 4:45pm
RE:Waiting
Looks like we didn't have to wait until the New Year to see the move. Pretty exciting times here!
(290)
•••
TheBridge
X
View Profile
View Bullboard History
Post by
TheBridge
on Nov 27, 2024 2:55pm
Waiting
Once this tax loss season is over we just might see this share price Awakin and start moving up. But as everyone knows these biotechs are a risky buiness and take a lot of time to determine whether
...more
(1)
•••
Badger66
X
View Profile
View Bullboard History
Post by
Badger66
on Sep 26, 2023 9:40am
Stifel - "‘Favourable Commercialization Outcome" PT C$1.75
Analysts at Stifel GMP expect a “favourable commercialization outcome” from Awakn Life Sciences Corp (NEO:AWKN)’s planned Phase 3 trial of novel ketamine drug AWKN-P001 in combination with
...more
(92)
•••
doggy123
X
View Profile
View Bullboard History
Comment by
doggy123
on Jun 13, 2023 9:17am
RE:RE:RE:RE:RE:RE:Seem
Unreal why scientists,doctors insiders in this company don't buy at market at this ridiculous price
(92)
•••
doggy123
X
View Profile
View Bullboard History
Comment by
doggy123
on Jun 09, 2023 9:24am
RE:RE:RE:RE:RE:Seem
Halted..........
(92)
•••
doggy123
X
View Profile
View Bullboard History
Comment by
doggy123
on Jun 05, 2023 11:00am
RE:RE:RE:RE:Seem
Q1 should be out pretty soon.......
(92)
•••
doggy123
X
View Profile
View Bullboard History
Comment by
doggy123
on May 12, 2023 9:18am
RE:RE:RE:Seem
This new company is a sleeping giant to a world of giant wide problem addictions.......Potential is so high with no interest yet.......watch it it's coming ....$$$
(92)
•••
doggy123
X
View Profile
View Bullboard History
Comment by
doggy123
on May 04, 2023 9:51am
RE:RE:Seem
Man i would like some comments on this stock.............level 2 is crazy so thin that with some good news this thing could pop up $2.00 plus $3.00 dollars almost instantly.......why some sell now is
...more
(92)
•••
doggy123
X
View Profile
View Bullboard History
Comment by
doggy123
on May 01, 2023 7:50pm
RE:Seem
Do your own dd.........Analyst Price target $1.75 buying recommendation rating by Yahoo
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing